Lipiroo 40 mg (Atorvastatin Calcium Trihydrate)

Adult dose

For the treatment of hyperlipidemia, the recommended initial dose is 10 mg of atorvastatin once daily, and if greater LDL cholesterol reduction is needed, it can be started at 20 mg or 40 mg once daily. This medication is administered once daily in the range of 10-80 mg, and the dosage should be adjusted individually based on treatment goals and patient response. Lipid levels should be checked within 2 to 4 weeks after starting therapy and the dosage should be adjusted accordingly.

This medication may cause abnormal muscle symptoms; therefore, it should be discontinued immediately if severe muscle pain or weakness occurs or if creatine kinase levels rise significantly. In particular, caution is required if serious myopathy or rhabdomyolysis is suspected, as it may lead to kidney function deterioration. This medication should not be used by patients with poor liver function or active liver disease, individuals with muscle disorders, pregnant women or women who may become pregnant, children under 10 years old, or those taking certain medications. Alcoholics or individuals with a history of liver disease, those with reduced kidney function, patients with hypothyroidism, and the elderly should be monitored more carefully when taking this medication. Although this medication generally has few side effects, it can exhibit various symptoms such as dyspepsia, headache, myalgia, liver function abnormalities, and allergic reactions; if any unusual symptoms occur, they should be reported. In particular, it is essential to consult a doctor immediately if muscle pain is severe or persists. This medication may interact with other drugs, so it is crucial to inform the doctor or pharmacist if any other medications are being taken. Women who are pregnant or breastfeeding should not take this medication, and fertile women should ensure appropriate contraception while on this medication. Caution is necessary for children and the elderly, as safety and efficacy have not been adequately established in these populations. There is no specific antidote for overdose, so management should be symptomatic, and liver function and muscle condition should be periodically assessed. This medication should be stored out of reach of children and kept in its original container to ensure safety.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweats, pallor, severe rash with fever, blisters, skin peeling, pain in oral/ocular mucosa, shortness of breath or difficulty breathing, asthma attacks, abnormal breathing accompanied by cough and fever, jaundice (yellowing of skin or eyes), profound lethargy, sudden and severe headache, thunderclap headache, seizures, altered consciousness, vision disturbances, paralysis, urinary dysfunction

Mild side effects

• Weakness
• fatigue
• chest pain
• peripheral edema
• tiredness
• fever
• rhinitis
• hyperglycemia
• hypoglycemia
• weight gain

This medication should be stored in a tightly closed container to prevent exposure to air and moisture and should be kept at room temperature between 1 and 30 degrees Celsius. Proper storage will maintain the medication's effectiveness and safety.

Appearance

White oval film-coated tablet

Package unit

30 tablets (10 tablets/PTP packaging x3), 30 tablets/bottle